Industry Innovations
Industry Innovations
Podcast Description
The National Lipid Association is proud to host Industry Innovations, a podcast series dedicated to showcasing the latest advancements in lipidology. Designed for clinicians, this series offers exclusive insights into cutting-edge science, research breakthroughs, and emerging therapies shaping the future of lipid management.
Podcast Insights
Content Themes
This podcast series focuses on key topics in lipid management, including advancements in RNA interference therapies, the role of inflammation in cardiovascular prevention, and innovative drug developments like LODOCO. Episodes such as From Innovation to Impact highlight novel approaches in lipid therapy, while Inflammation and Heart Attacks delves into cutting-edge preventive measures against cardiovascular events, bringing attention to evidence-backed clinical data.
The National Lipid Association is proud to host Industry Innovations, a podcast series dedicated to showcasing the latest advancements in lipidology. Designed for clinicians, this series offers exclusive insights into cutting-edge science, research breakthroughs, and emerging therapies shaping the future of lipid management.
In this compelling episode of NLA Industry Innovations, host Kevin Maki, PhD, MNLA sits down with renowned lipidologist and clinical researcher Michael Davidson, MD, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market.
Dr. Davidson offers a behind-the-scenes look at how pharmaceutical companies weigh scientific promise, regulatory pathways, market dynamics, and patient needs when developing new therapies. The conversation also touches on the challenges of balancing innovation with accessibility, and why some promising treatments never reach the shelves.
Whether you're a clinician, researcher, or industry insider, this episode provides valuable insights into the forces driving therapeutic advancement in lipidology and beyond.
Sponsored by New Amsterdam Pharma
Featuring
Michael H. Davidson, MD, ABCL, MNLA
NewAmsterdam Pharma,
Naarden, The Netherlands
Lipid Clinic, Pritzker School of Medicine,
University of Chicago,
Chicago, IL, USA
Guest Host:
Kevin Maki, PhD, CLS, MNLA
Chief Scientist, Midwest Biomedical Research
Adjunct Professor, Dean’s Eminent Scholar
Indiana University School of Public Health
Bloomington, IN
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.